During the past decade, Swedish Cancer Institute-Issaquah conducted 154 clinical trials. In the 10-year time frame, 154 clinical trials started and 77 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 66 clinical trials started and 61 clinical trials were completed. i.e. 92.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Swedish Cancer Institute-Issaquah" #1 sponsor was "National Cancer Institute (NCI)" with 101 trials, followed by "SWOG Cancer Research Network" with 38 trials sponsored, "Alliance for Clinical Trials in Oncology" with 33 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 15 trials sponsored and "Gynecologic Oncology Group" with 15 trials sponsored. Other sponsors include 12 different institutions and companies that sponsored additional 17 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Swedish Cancer Institute-Issaquah" #1 collaborator was "National Cancer Institute (NCI)" with 99 trials as a collaborator, "NRG Oncology" with 16 trials as a collaborator, "Canadian Cancer Trials Group" with 8 trials as a collaborator, "Genentech, Inc." with 3 trials as a collaborator and "Astellas Pharma US, Inc." with 2 trials as a collaborator. Other collaborators include 26 different institutions and companies that were collaborators in the rest 34 trials.

According to Clinical.Site data, the most researched conditions in "Swedish Cancer Institute-Issaquah" are "Recurrent Squamous Cell Lung Carcinoma" (9 trials), "Breast Cancer" (7 trials), "Invasive Breast Carcinoma" (7 trials), "Stage IV Lung Cancer AJCC v8" (7 trials) and "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (7 trials). Many other conditions were trialed in "Swedish Cancer Institute-Issaquah" in a lesser frequency.

Most popular intervention types in "Swedish Cancer Institute-Issaquah" are "Drug" (172 trials), "Other" (118 trials), "Biological" (90 trials), "Procedure" (55 trials) and "Radiation" (23 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (57 trials), "Quality-of-Life Assessment" (48 trials), "Questionnaire Administration" (35 trials), "Computed Tomography" (32 trials) and "Biospecimen Collection" (29 trials). Other intervention names were less common.

The vast majority of trials in "Swedish Cancer Institute-Issaquah" are 176 trials for "All" genders, 28 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "Swedish Cancer Institute-Issaquah". undefined are not yet recruiting, 63 are recruiting, 98 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 34 completed trials in Swedish Cancer Institute-Issaquah, 5 suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Swedish Cancer Institute-Issaquah, 9 "Phase 1" clinical trials were conducted, 105 "Phase 2" clinical trials and 102 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 5 trials that are defined as “Not Applicable".